Skip to main content
Harvard Bioscience, Inc. (HBIO)
NASDAQ: HBIO · Real-Time Price · USD
6.40
-0.05 (-0.78%)
Apr 29, 2026, 9:56 AM EDT - Market open

Harvard Bioscience Revenue

In the year 2025, Harvard Bioscience had annual revenue of $86.55M, down -8.06%. Harvard Bioscience had revenue of $23.74M in the quarter ending December 31, 2025, a decrease of -3.34%.

Revenue (ttm)
$86.55M
Revenue Growth
-8.06%
P/S Ratio
0.33
Revenue / Employee
$255,310
Employees
339
Market Cap
28.87M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202586.55M-7.59M-8.06%
Dec 31, 202494.14M-18.12M-16.14%
Dec 31, 2023112.25M-1.09M-0.96%
Dec 31, 2022113.34M-5.57M-4.68%
Dec 31, 2021118.90M16.80M16.46%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Retractable Technologies 38.27M
Precision Optics Corporation 24.42M
Jin Medical International 20.69M
Nephros 18.79M
Ekso Bionics Holdings 12.80M
Milestone Scientific 8.97M
Femasys 2.29M
Zentek 687.67K
Revenue Rankings

HBIO News

More News